Carolyn M. Brown on Muck Rack

Carolyn M. Brown

New York
As seen in: Diversity Woman Magazine, Forbes, BBC, British Journal of Cancer, Business Insider, Nature, Inc., The Times, Condé Nast Traveler, Town & Country, Black Enterprise, Cruise Critic (U.S.) and
Content creator~publishing, digital, broadcast, events. Founder, My True Colors Festival. Author, playwright, producer. Small Biz, Arts, Activism Social Justice
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Carolyn M.

Contact Carolyn M., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

PCR173 SOCIAL AND STRUCTURAL DETERMINANTS OF BUPRENORPHINE ADHERENCE AMONG INDIVIDUALS WITH OPIOID USE DISORDER

|
By Carolyn M. Brown, Tiffany Whittaker, Tyler Jordan Varisco, Anton Avanceña, Tyler Jordan Varisco, Leticia Rae Moczygemba
| Value in Health Journal Verified
College of Pharmacy, The University of Texas at Austin, Austin, TX, USA Department of Educational Psychology, The University of Texas at Austin, Austin, TX, USA
Open in Who Shared Issue with article?

Lionel Rosenblatt: The Refugee Advocate Who Started in Vietnam

|
By Carolyn M. Brown
| misryoum.com
Lionel Rosenblatt is gone. He was 82, a number that somehow feels too small for the scope of the work he actually managed to pull off. According to Misryoum, his journey into advocacy didn’t start in some stuffy office with a desk and a rotary phone, but rather through the chaos and, frankly, the sheer danger of Vietnam. He was the kind of guy who didn’t wait for permission when he saw something fundamentally broken.
Open in Who Shared Issue with article?

Trump strikes deal with Ozempic and Mounjaro makers to cut prices of obesity injections

|
By Carolyn M. Brown
| buff.ly
Donald Trump has signed deals with the pharma giants Novo Nordisk and Eli Lilly to lower the prices of antiobesity drugs and get more US citizens taking them. The deal will cover tirzepatide (Lilly’s Zepbound and Mounjaro) and semaglutide (Novo’s Wegovy and Ozempic). Both companies join a growing list of drug manufacturers promising to give US consumers “most favoured nation” pricing for new drugs.
Open in Who Shared Issue with article?
See all 1,113 licensed articles (1,114 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified